Epidemiology of AIDS--statistical analyses. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Epidemiology of AIDS--statistical analyses.

J Epidemiol Community Health. 1987 Mar;41(1):55-8. Unique Identifier : AIDSLINE MED/88034837
Iversen OJ; Engen S; Department of Microbiology, University of Trondheim, Norway.

Abstract: Some central questions concerning the epidemiology of AIDS are addressed by statistical analyses. Applying standard maximum likelihood theory to reported cases of transfusion-associated AIDS in the US, the mean and standard deviation of incubation time for AIDS are estimated to be about 60 and 19 months, respectively. If these parameters are applied to the data from the San Francisco CDC cohort study, we find a good correspondence between estimated and reported cases of AIDS when the probability factor p is 0.27-meaning that about 27% of those infected with HIV are expected to develop AIDS during a period of 8-10 years. Application of the incubation time model and the probability factor p to the data on transfusion-associated AIDS makes it possible to estimate the number of transfusion-associated infections with HIV from 1978 to 1984. These estimates give an exponential increase in the number of cases, with a relative increase of 2.74 each year. It seems reasonable to assume that this increase reflects the spread of the virus within this period.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/ETIOLOGY Blood Transfusion/ADVERSE EFFECTS Human Probability Statistics United States JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDepidemiology/etiologybloodtransfusion/adverseeffectshumanprobabilitystatisticsunitedstatesjournalarticle
880228
M8820318

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .